Wikidata

(Q54460024)

English

Phase I study of VP-16 (etoposide) and amsacrine (AMSA) in the treatment of refractory acute leukemia.

scientific article

In more languages

Statements

title
Phase I study of VP-16 (etoposide) and amsacrine (AMSA) in the treatment of refractory acute leukemia. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
3839284
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/3839284

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q54460024&oldid=1582961078"